Compare NDSN & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NDSN | WST |
|---|---|---|
| Founded | 1935 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 16.6B |
| IPO Year | 1997 | 2004 |
| Metric | NDSN | WST |
|---|---|---|
| Price | $292.30 | $241.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $294.00 | ★ $319.43 |
| AVG Volume (30 Days) | 392.3K | ★ 1.1M |
| Earning Date | 05-18-2026 | 05-15-2026 |
| Dividend Yield | ★ 1.12% | 0.36% |
| EPS Growth | ★ 4.93 | 1.49 |
| EPS | 2.38 | ★ 6.79 |
| Revenue | $2,254,668,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $6.24 | $6.83 |
| Revenue Next Year | $4.92 | $6.18 |
| P/E Ratio | $123.76 | ★ $35.82 |
| Revenue Growth | ★ 9.08 | 1.95 |
| 52 Week Low | $165.03 | $187.43 |
| 52 Week High | $305.28 | $322.34 |
| Indicator | NDSN | WST |
|---|---|---|
| Relative Strength Index (RSI) | 61.87 | 45.08 |
| Support Level | $293.54 | $227.49 |
| Resistance Level | $305.28 | $251.81 |
| Average True Range (ATR) | 6.03 | 9.97 |
| MACD | -0.60 | 1.56 |
| Stochastic Oscillator | 52.66 | 44.71 |
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.8 billion in revenue in its fiscal 2025.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.